Articles:
Publications:

Jul. 20, 2026

Takeda Secures DCGI Nod For India's First Dengue Vaccine QDENGA

Takeda Secures DCGI Nod For India's First Dengue Vaccine QDENGA

Japan-based Takeda Biopharmaceuticals has received approval from the Drug Controller General of India (DCGI) for its QDENGA dengue vaccine, making it the first vaccine authorized in India for the prevention of dengue. The approval marks a... Read more.

More on this topic

IOL 2 hours ago
Turn on Transparency.
Anxiety is rising as South Africa prepares for a possible Ebola outbreak
Owner: Iqbal Survé through Sekunjalo Investments; Chinese Government through China International Television Corporation & The China Africa Development Fund; South African Government through The Public Investment Corporation of South Africa More info
Turn on Transparency.
UK Responds To Potential Ebola Exposure With Emergency Medical Transfer
Owner: David Jang through IBT Media More info
The New Yorker an hour ago
Turn on Transparency.
“No One Knows When It Will End”: A Doctor on the Ebola Emergency
Owner: Newhouse Family through Advance Publications & Condé Nast More info
More

More from Silicon India

Silicon India 2 hours ago
Turn on Transparency.
India Sends Medical Aid to Kenya to Boost Ebola Preparedness
Owner: Harvi Sachar More info
Silicon India 2 hours ago
Turn on Transparency.
Zydus Life Gets USFDA Nod for Sickle Cell Drug Phase III Trial
Owner: Harvi Sachar More info
Silicon India Jul. 20, 2026
Turn on Transparency.
Takeda Secures DCGI Nod For India's First Dengue Vaccine QDENGA
Owner: Harvi Sachar More info
More

Keep exploring Perspectify!

Create a free account and bring
more transparency to your news.

Already have an account? Log in.

Today's Media Watch

Your daily guide to the stories shaping media, journalism, and public trust.

Jul. 22, 2026
French Lawmakers Approve a Sweeping Social Media Ban for Children Under 15
Neutral | Owner: BCE Inc.
Jul. 22, 2026
Federal Judge Hands Fact-Checking Journalists, Researchers a First Amendment Win in Trump Administration Immigration Case
Neutral | Owner: The Poynter Institute for Media Studies

Learn About Our Fact-Based Transparency System

Our proprietary bias labels help you understand each outlet’s political orientation, editorial independence, and credibility based on factors like ownership, funding, affiliations, content, and media freedom. Learn more in the Perspectify FAQ.

Learn more